Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Myelos Corp.

Division of Horizon Therapeutics PLC
www.myelos.com

Latest From Myelos Corp.

Myelos Corp.

Myelos Corp. was applying its novel derivatives of neurotrophic factor prosaposin to the difficult problem of nerve damage caused by diabetes and other diseases, when it discovered, through serendipity, the pain-relieving potential of its compound.
BioPharmaceutical

New Drugs for Pain

Spectacular failures in stroke and neurodegenerative diseases have given drug developers a black eye, but along the way, the insights they've gleaned in neurobiology have revealed new targets for pain. Unfortunately, the targets keep moving.
BioPharmaceutical

Selected Start-Ups Founded in 2000 (0002)

{In Vivo} summarizes the technologies of several medical companies founded recently, including Belgium's [AlgoNomics NV], a new entrant in the biocomputing and bioinformatics arena. [CoPharma Inc.]'s mission is to develop drug and biological products through joint ventures with discovery firms. Launched in February 2000 with $2 million from Sanderling, Alta Partners and Graystone, [Cythera Inc.] will develop therapies based on the transplantation of functional human cells grown{ in vitro}, offering an alternative to the use of donated human tissues. [Embolic Protection Inc.] has developed a device, consisting of a guide wire and filter mechanism, to remove embolic debris. Denmark's [NsGene A/S] is a joint venture of NeuroSearch A/S and the University of Lund. [WebEBM] will offer evidence-based clinical guidelines for 400 diseases or conditions on its website.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Horizon Therapeutics PLC
  • Senior Management
  • Andres Barnes, Pres.
    David Wright, PhD, Dir., Chemistry & Drug Dev.
    Charlotte Clark, VP, Bus. Dev.
  • Contact Info
  • Myelos Corp.
    Phone: (858) 657-1040
    4940 Carroll Canyon Rd.
    Ste. M
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register